Schaeffer's Top Stock Picks for '25

Analyst Downgrades: Bed Bath & Beyond Inc., Valeant Pharmaceuticals Intl Inc, and Tesla Motors Inc

Analysts downwardly revised their ratings and price targets on Bed Bath & Beyond Inc. (NASDAQ:BBBY), Valeant Pharmaceuticals Intl Inc (NYSE:VRX), and Tesla Motors Inc (NASDAQ:TSLA)

Jun 23, 2016 at 9:06 AM
facebook X logo linkedin


Analysts are weighing in on home goods retailer Bed Bath & Beyond Inc. (NASDAQ:BBBY), biotech stock Valeant Pharmaceuticals Intl Inc (NYSE:VRX), and automaker Tesla Motors Inc (NASDAQ:TSLA). Here's a quick roundup of today's bearish brokerage notes on BBBY, VRX, and TSLA.

  • BBBY is down almost 4% in pre-market trading, following the company's disappointing first-quarter earnings release. This was met with a round of bearish analyst attention, including price-target cuts from no fewer than eight brokerage firms. Among the bunch was Credit Suisse, setting the lowest mark at $41. Bearish analyst attention is nothing new for Bed Bath & Beyond Inc., though. Just one of the 16 analysts providing coverage on the stock recommends buying it. And it's no wonder, considering BBBY has fallen almost 39% in the past 12 months, to trade at $43.18. 

  • VRX is edging 1.1% higher ahead of the open, despite a downgrade to "neutral" from "overweight" at J.P. Morgan Securities, which also cut its price target to $35 from $50. The stock closed Wednesday at $21.64, rebounding slightly after hitting fresh multi-year lows earlier this week. Despite its technical struggles, Valeant Pharmaceuticals Intl Inc bulls can still be found on Wall Street and in the options pits. For instance, five analysts still consider the stock a "strong buy," while VRX's Schaeffer's put/call open interest ratio (SOIR) of 0.63 marks a 12-month call-skewed low. 
  • TSLA looks poised to continue Wednesday's sell-off, as analysts turn bearish following the company's "no brainer" M&A announcement. Just this morning, Morgan Stanley downgraded the stock to "equal weight," while Berenberg lowered its price target to $145 from $150. While this is far below Tesla Motors Inc's Wednesday settlement at $196.66, the stock was trading below $145 as recently as February. Another day in the red could put TSLA in oversold territory, with the stock's 14-day Relative Strength Index (RSI) registering at 31 as of yesterday's close -- right above the oversold threshold. 
Sign up now for Schaeffer's Opening View newsletter to get a head start on all the major pre-market news!
 
 

You have the chance to join one of Bernie's most exclusive programs, complete access at HUGE savings!

As we prepare for a new administration to take the reins in Washington, the near-term market landscape is rife with uncertainty.

The Federal Reserve has already hinted at the turbulence ahead, lowering its interest rate outlook for 2025.

Meanwhile, breakthroughs in artificial intelligence (AI), quantum computing, and other transformative sectors have unlocked incredible profit potential.

But these opportunities are fleeting, and timing is everything. That's where Quick-Hit Trader comes in.

Quick-Hit Trader is designed for precision and speed, getting you in and out of the market in a flash. While other investors scramble to navigate volatile conditions, you'll have access to expertly curated trades that leverage these rapid shifts to deliver explosive profits in short order.

This is your chance to capitalize on the fast-moving market like never before. Are you ready to make your move?